Celularity and Versea Ophthalmics to commercialize ophthalmic allografts
Celularity - 27-Jul-2023Innovative BIOVANCE single- and three-layer products for ocular surface disease treatment & surgical support
Join the club for FREE to access the whole archive and other member benefits.
Life-science company to deliver innovative diagnostic and therapeutic solutions to improve health care
Verséa Health is a transformative healthcare company committed to delivering innovative, high-value diagnostic and therapeutic point-of-care (POC), over-the-counter (OTC) and lab-based solutions across a broad range of diseases. Verséa Health takes a proactive approach in our current reactive healthcare system. The company was founded in 2018.
Leveraging its channel expertise and strategic industry partnerships the company has been successful in building long-term trusted relationships with thousands of healthcare providers (physicians, practices, laboratories, and large medical centers) and retail companies throughout the country.
Product Portfolio consists of POC, OTC, and lab-based testing solutions for infectious and non-infectious diseases, drugs of abuse, pregnancy & ovulation,
Verséa has 4 strategic business units: Verséa Diagnostics; Verséa Therapeutics; Verséa Ophthalmics; Verséa Discovery
Each business unit provides unique value to the healthcare community and drives commercial success of Verséa.
Visit website: https://www.versea.com/
Details last updated 05-Aug-2023
Innovative BIOVANCE single- and three-layer products for ocular surface disease treatment & surgical support